@zecs the only phase I/II trial that has been going for any length of time was the burns trial. this was investigator sponsored and therefore beyond RCE 's control. phase I dosing trial for IV dosing has not long concluded and is critical for establishing safety but is not indication specific. each indication will likely need a specific phase II and III trial. the Foot ulcer trial and the uTi trial are all progressing to the next phase in a timely manner. what were your expectations? drugs on average take 10 years and a billion dollars to get approved. RCE is well short of that
Ann: R327 added to WHO List of Antibacterial Products, page-16
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $87.95M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 30.5¢ | $27.74K | 87.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 20322 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 69366 | 1 |
View Market Depth
| Last trade - 10.44am 18/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |